Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
This effectively reduces the net cost by 2035% for individuals in higher tax brackets, as HSA/FSA contributions are pre-tax
Below is a timeline of confirmed developments and expected events in 2026 based on manufacturer announcements, FDA filings, and major media reporting
Once all fields are completed and reviewed, save your progress by clicking the save button
In head-to-head comparisons from trial data: Semaglutide 2.4 mg produces around 15% body weight loss over 68 weeks (STEP 1 trial) Tirzepatide 15 mg produces around 20.9% body weight loss over 72 weeks (SURMOUNT-1 trial) Retatrutide 12 mg produced 24.2% body weight loss over 48 weeks (Phase 2 trial, NEJM 2023) Retatrutide is producing more weight loss in less time
US$ 23.27
US$ 28.23
US$ 28.78
US$ 27.99
US$ 22.05
